Vor Ort
Merkzettel Warenkorb
  • Produktbild: Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications
  • Produktbild: Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications
Band 18

Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications

Aus der Reihe Medical Science Symposia Series

97,99 €

inkl. gesetzl. MwSt., Versandkostenfrei

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

14.10.2012

Abbildungen

XVI, 172 p.

Herausgeber

J.-C. Fruchart + weitere

Verlag

Springer Us

Seitenzahl

172

Maße (L/B/H)

23,5/15,5/1,1 cm

Gewicht

306 g

Auflage

Softcover Reprint of the Original 1st 2002 edition

Sprache

Englisch

ISBN

978-1-4613-5427-7

Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

14.10.2012

Abbildungen

XVI, 172 p.

Herausgeber

Verlag

Springer Us

Seitenzahl

172

Maße (L/B/H)

23,5/15,5/1,1 cm

Gewicht

306 g

Auflage

Softcover Reprint of the Original 1st 2002 edition

Sprache

Englisch

ISBN

978-1-4613-5427-7

Herstelleradresse

Libri GmbH
Europaallee 1
36244 Bad Hersfeld
DE

Email: gpsr@libri.de

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)
  • Produktbild: Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications
  • Produktbild: Peroxisome Proliferator Activated Receptors: From Basic Science to Clinical Applications
  • 1. Peroxisome Proliferator Activated Receptor Alpha Coordinates Intermediary Metabolism During Fasting.- 2. Design, Structure, and Function of Novel PPAR Ligands.- 3. Functions of PPAR Gamma in Macrophages and Atherosclerosis.- 4. PPARs and Atherogenesis: Mediators or Modulators of the Inflammatory Response in the Vessel Wall?.- 5. Role of PPARs in Inflammation, Atherosclerosis, and Thrombosis.- 6. Effects of Thiazolidinediones on Vascular Reactivity and Endothelial Dysfunction.- 7. Activation of Human PPAR Subtypes by Pioglitazone.- 8. PPAR? Mechanism of Action Studies.- 9. The Role of PPAR? in Fatty Acid Metabolism and Hepatocarcinogenesis: Studies with PPAR?-Null Mice.- 10. PPAR?, Lipoprotein Metabolism, Metabolic Disease, and Atherosclerosis.- 11. PPAR? and Atherosclerosis.- 12. Regulation of CD36 by PPAR?: Pro- or Anti-atherogenic?.- 13. Anti-inflammatory Properties of High Density Lipoproteins.- 14. The Low-HDL Syndrome: Epidemiology and Pathophysiology.- 15. Diabetes: A Growing CHD Epidemic.- 16. Influence of PPARs on Muscle Lipid Metabolism and Insulin Resistance.- 17. PPAR? in Adipogenesis and Insulin Resistance.- 18. Pharmacology of a Selective Peroxisome Proliferator-Activated Receptor ? Agonist, GW501516, in Obese Dyslipidemic Primates.- 19. PPAR?: A Regulator of Growth and Differentiation.- 20. Peroxisome Proliferator Activator Receptor Gamma Agonists Inhibit the Development of Atherosclerosis in Low Density Lipoprotein Receptor-Deficient Male Mice.- 21. Are Thiazolidinediones Superior to Standard Therapy in the Treatment of Type 2 Diabetes?.- 22. PPAR? Ligands and Intestinal Inflammation.- 23. Inflammatory Mechanisms in Alzheimer’s Disease: ?-Amyloid-Stimulated Proinflammatory Responses Are Blocked by PPAR? Agonists.